FDA Gives Firms Hawking H1N1 Remedies Tighter Deadline To Comply
This article was originally published in The Tan Sheet
Executive Summary
FDA's threats of near-immediate action against firms selling products with claims of treating the 2009-H1N1 flu virus are the sign of a fleet-footed and serious agency, says a food and drug attorney
You may also be interested in...
In Brief
Valeant picks up skin care OTCs from J&J; FDA finds ‘supplements’ making anti-meningitis claims; Capsugel supplies Mercola.com; investigation charge slows Omega Protein; Vitacost continues diversifying sales mix more news in brief.
AHPA Says H1N1 Enforcement Tactics Would Work To Find Hidden Steroids
The American Herbal Products Association urges FDA to crack down on illegal steroids masquerading as dietary supplements with the "efficient" enforcement tactics the agency uses to pursue fraudulent H1N1 flu products
AHPA Says H1N1 Enforcement Tactics Would Work To Find Hidden Steroids
The American Herbal Products Association urges FDA to crack down on illegal steroids masquerading as dietary supplements with the "efficient" enforcement tactics the agency uses to pursue fraudulent H1N1 flu products